Literature DB >> 6993994

Multiple sclerosis: evidence for immunopathogenesis.

R P Lisak.   

Abstract

I have attempted to review the evidence that one or more immunopathologic mechanisms are responsible for the clinical and pathologic findings in multiple sclerosis (MS). I believe that there is considerable evidence for an immunopathogenesis of MS, but it is not clear what type or types of reactions are involved or against which autoantigen, neoantigen, or microbial antigen the reaction is directed. In addition, there is growing evidence that there are abnormalities in immunologic control mechanisms in patients with MS, although whether these changes are a cause or a result of the disease is not clear.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6993994     DOI: 10.1212/wnl.30.7_part_2.99

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  T-lymphocyte subsets modifications in multiple sclerosis: correlation with clinical disease activity.

Authors:  M Prencipe; E Salerni; C D'Aurizio; C Marini; D Adorno; A M Berghella; P Pellegrini; F Papola; C U Casciani
Journal:  Ital J Neurol Sci       Date:  1986-12

2.  Lymphocytoplasmapheresis in multiple sclerosis: one-year results in 6 patients.

Authors:  A Ghezzi; G A Zaffaroni; D Caputo; R Guaschino; D Alesso; P Gasco; R Montanini; C L Cazzullo
Journal:  Ital J Neurol Sci       Date:  1986-02

3.  Coxsackievirus induced myocarditis in mice: cardiac myosin autoantibodies do not cross-react with the virus.

Authors:  N Neu; S W Craig; N R Rose; F Alvarez; K W Beisel
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

Review 4.  Characterization and distribution of lymphocyte subpopulations in multiple sclerosis plaques versus autoimmune demyelinating lesions.

Authors:  U Traugott
Journal:  Springer Semin Immunopathol       Date:  1985

Review 5.  Immunoregulatory T cells in multiple sclerosis: markers and functions.

Authors:  M A Bach
Journal:  Springer Semin Immunopathol       Date:  1985

6.  Monoclonal antibody-defined immunoregulatory cells in multiple sclerosis cerebrospinal fluid.

Authors:  N Cashman; C Martin; J F Eizenbaum; J D Degos; M A Bach
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

7.  Beta-arrestin and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients.

Authors:  H Ohguro; S Chiba; Y Igarashi; H Matsumoto; T Akino; K Palczewski
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Lactoferrin, lysozyme, and beta 2-microglobulin levels in cerebrospinal fluid: differential indices of CNS inflammation.

Authors:  R Hällgren; A Terént; P Venge
Journal:  Inflammation       Date:  1982-09       Impact factor: 4.092

9.  Brain tissue immunoglobulins in adrenoleukodystrophy: a comparison with multiple sclerosis and systemic lupus erythematosus.

Authors:  H Bernheimer; H Budka; P Müller
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

10.  Endogenous interleukin-6 amplifies interleukin-17 production and corticoid-resistance in peripheral T cells from patients with multiple sclerosis.

Authors:  Thais B Ferreira; Joana Hygino; Priscila O Barros; Bruna Teixeira; Taissa M Kasahara; Ulisses C Linhares; Lana Márcia F Lopes; Claudia Cristina F Vasconcelos; Regina Alvarenga; Ana Cristina Wing; Regis M Andrade; Arnaldo F B Andrade; Cleonice A M Bento
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.